Ebanga FDA Approval History
Last updated by Judith Stewart, BPharm on Jan 25, 2021.
FDA Approved: Yes (First approved December 21, 2020)
Brand name: Ebanga
Generic name: ansuvimab-zykl
Dosage form: Injection
Company: Ridgeback Biotherapeutics, LP.
Treatment for: Zaire Ebolavirus Infection
Ebanga (ansuvimab-zykl) is a monoclonal antibody for the treatment of Zaire ebolavirus (Ebolavirus) infection in adults and children.
Development timeline for Ebanga
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.